ELI LILLY & CO · held by 1 fund · data as of 2026-06-03
Sector
Healthcare
Industry
Drug Manufacturers - General
Market cap
$948.95B
Price
$1,088.15
12-mo
+42.30%
P/E
38.6
Div yield
0.64%
Held by
1 fund
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, such as Cyramza for the sec…